Skip to main content
. 2021 May 28;13(6):809. doi: 10.3390/pharmaceutics13060809

Figure 3.

Figure 3

Ishikawa diagram of developing a system for in vitro penetration measurements of nasal powders, the most influencing factors are highlighted in red.